Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
The photos are reduced to (100 100 3) and (128 128 3) for classification and segmentation, respectively, in the RGB color space
Key Industry Highlights: Dominant Segment : Ozempic leads the GLP-1 receptor agonist market in 2025 , with a 32.1% share , driven by its strong clinical efficacy in HbA1c reduction, proven cardiovascular benefits, and superior weight-loss outcomes
Nacharam | Pragathi Nagar | Manikonda [Weight loss drugs, Thyroid cancer, Thyroid health, Weight loss medication, GLP-1 medications, Family history of thyroid cancer, Endocrinologist Hyderabad, Thyroid specialist, Obesity treatment] #WeightLossDrugs #obesitytreatment #endocrinologist #prasadhospitals #prasadhospitalsmanikonda | Prasad Hospitals
Ongoing review helps us keep that balance
US$ 22.54
US$ 25.54
US$ 24.05
US$ 20.88
US$ 22.59
US$ 26.03
US$ 20.70
US$ 20.14
US$ 28.88
